Gender-Specific Medicine in Cardiovascular Disease -Up to Date-

Gender difference is an important factor for the prevention, pathogenesis and treatment in cardiovascular diseases. In 2010, “Guideline for Gender-specific Medicine in Cardiovascular Disease” was published from the Japanese Circulation Society. This guideline aimed to collect evidences concerning with gender difference in cardiovascular diseases, and let researchers know how evidence-based medicine for the prevention of cardiovascular disease in women is scanty. However, the spread of gender-specific medicine and gender-based pathobiology are still insufficient in Japan.
  In the USA, NIH and FDA have promoted gender-specific medicine since 1990's, and is the one of the leading countries in this field. In this session, we expect extensive discussion with Dr. Merz, a Director of the Women's Heart Center at the Cedars-Sinai Heart Institute, regarding the women and heart disease. We hope that this session will be a trigger to promote research, education and medical care of gender-specific medicine in Japan.